Introduction
This invited presentation will give a brief overview with regard the evolution of microelectronic implants and then describe hotil the dominant semiconductor, silicon, can be made much more biocompatible than previously imagined. A summary of perceived applications in different clinical areas will then be given.
Biomedical MEMS : Clinical use of sllicon technology Microelectronic implanb within the human body have a history almost as long as that of microelectronics. The most well known, the cardiac "pacemake/', was first implanted in 1960 but even prior to this "radio pills" were being swallowed and tested in-vivo. Today, there are a range of electrical stimulation devices for both cardiovascular and neurological conditions. There are programmable pumps for tdrminal cancer patiente and cochlear implants for the profoundly deaf.
To date it has been necessary in all FDA-approved devices to completely isolate the chip from the body by packaging with other biomaterials.
The emergence of bioMEMS and some synergistic major trends in clinical medicine, namely ;
. minimally invasive & robotic surgery . home-based monltoring systems and telemedicine ' smarter, more reactive prostheses will converge to make biomedical applications the fastest growing MEMS market over the next few years. This market pressure will further promote development of smaller and interac.tive systems for implanlation. Nanosfuctured silicon as a biomedical material Surprisingly little development of silicon for biomaterial use occuned prior to the 1990's, atthough in cortical tissue it had been earlier found to be "non-reac'tive" (1). Non-porous monocrystalline silicon and many sintered polycrystalline structures do not exhibit pronounced conosion in physiological environments. Very thin (2 micron) pieces of silicon have been soaked in saline for years and implanted in guinea pigs for over 11 months with negligible dissolution in either case (2) . In striking contrast, it was shown in 1995 (3) that a 1 micron thick layer of high porosity siticon completely dissolved away within a day of in-vitro immersion in simulated human plasma. In addition, poly-si of nanometre grain size was subsequently shown to undergo appreciable corosion (4). lt was proposed (3) that nanostructured forms of silicon could be resorbable, breaking down into silicic acid by hydrolysis, which is efiiciently excreted by the kidneys. This exciting prospect received in-vivo confirmation from a 6 month study of bulk and porous silicon discs in subcutaneous tissue of guinea pigs (5) . Here the partially porosified discs continually lost weight, as opposed to the bulk silicon and titanium controls. . bioMEMS implant packaging Porous silicon coatings, when combined with hermetic sealing via wafer-to-wafer bonding or "poly-Si bubble" processing, enable Si packaging designs that will enable integration of the chip itself with living tissue.
(1) Histopathological evaluation of materials implanted in the cerebral cortex. 
